ChronoScale Corporation (CHRN) Key Metrics
CHRN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $2.19B
- Enterprise value
- $3.12B
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 30.7
- Price / book
- 16.7
- EV / EBITDA
- 151.1
- Dividend yield
- —
- Beta
- 0.98
CHRN key metrics, FY2025–FY2026
Fiscal year ended May 31, 2026 · U.S. dollarsCHRN valuation Price multiples at each fiscal year-end price.
CHRN returns How much profit the business earns on the capital it uses.
CHRN per-share figures Results divided by the shares outstanding at year-end.
CHRN financial health Debt, liquidity and how easily interest is covered.
CHRN efficiency & capital use Working capital cycle and where the cash goes.
CHRN valuation history
CHRN returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CHRN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CHRN cash returned to shareholders
CHRN price vs earnings per share
CHRN key metrics
FY2025–FY2026| FY2026 | FY2025 | |
|---|---|---|
| Valuation | ||
| Market capitalization | $2.67B | $648.2M |
| Enterprise value | $2.66B | $657.8M |
| Price / sales | 37.2 | 7.7 |
| Price / book | 14.8 | 8.5 |
| Price / free cash flow | 218.7 | — |
| Price / operating cash flow | 68.2 | — |
| EV / sales | 37.1 | 7.8 |
| EV / EBITDA | 128.8 | 26.0 |
| EV / free cash flow | 217.9 | — |
| Earnings yield | −1.9% | −11.2% |
| Free cash flow yield | 0.5% | −1.3% |
| Shareholder yield (dividends + buybacks) | 0.0% | 0.0% |
| Share price at fiscal year-end | $18.36 | $4.53 |
| Per share | ||
| Revenue per share | $0.49 | $0.59 |
| Earnings per share | −$0.35 | −$0.51 |
| Operating cash flow per share | $0.27 | −$0.05 |
| Free cash flow per share | $0.08 | −$0.06 |
| Cash per share | $0.07 | $0.02 |
| Book value per share | $1.24 | $0.53 |
| Tangible book value per share | $0.86 | $0.53 |
| Capex per share | $0.19 | $0.01 |
| Debt per share | $0.00 | $0.08 |
| Shares outstanding | 145.2M | 143.1M |
| Change in shares outstanding | +1.5% | — |
| Returns & profitability | ||
| Return on equity (ROE) | −39.3% | −95.5% |
| Return on invested capital (ROIC) | −22.7% | −51.4% |
| Return on assets (ROA) | −16.0% | −23.9% |
| Return on tangible assets | −18.5% | −23.9% |
| Free cash flow margin | 17.0% | −10.2% |
| Financial health | ||
| Total debt | $474,000 | $12.0M |
| Cash & short-term investments | $9.7M | $2.4M |
| Net debt | −$9.2M | $9.6M |
| Debt / equity | 0.00 | 0.16 |
| Debt / assets | 0.00 | 0.04 |
| Net debt / EBITDA | −0.45 | 0.38 |
| Current ratio | 0.51 | 0.04 |
| Quick ratio | 0.51 | 0.04 |
| Interest coverage | -3.9 | -3.2 |
| Working capital | −$42.6M | −$151.2M |
| Invested capital | $170.8M | $85.8M |
| Tangible asset value | $125.5M | $76.2M |
| Net current asset value | −$101.6M | −$221.6M |
| Graham net-net per share | −$0.87 | −$1.56 |
| Capital allocation | ||
| Share buybacks (net) | $750,000 | $0 |
| Dividends + buybacks / free cash flow | 6.2% | — |
| Capex / revenue | 37.5% | 1.6% |
| Capex / operating cash flow | 68.8% | — |
| Capex / depreciation | 0.45 | 0.02 |
| Stock-based compensation / revenue | 1.8% | −1.7% |
| SG&A / revenue | 27.7% | 29.4% |
| Efficiency | ||
| Days sales outstanding | 41.6 | 16.4 |
| Days payables outstanding | 26.8 | 12.5 |
| Cash conversion cycle (days) | 14.8 | 3.8 |
| Receivables turnover | 8.77 | 22.27 |
| Payables turnover | 13.63 | 29.10 |
| Asset turnover | 0.23 | 0.28 |
| Average receivables | $8.2M | $3.8M |
| Average payables | $6.5M | $4.0M |
| Intangibles / total assets | 16.7% | 0.0% |
Computed from CHRN's annual financial statements (latest annual report filed —) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CHRN valuation and financial ratios
ChronoScale earned a return on equity of −39.3% and a return on invested capital of −22.7% in fiscal 2026. It ended the year with $0.5 million of debt and $9.7 million in cash and short-term investments, a net cash position of $9.2 million. It returned $0.8 million to shareholders: $0 in dividends and $0.8 million in share buybacks, 6% of free cash flow.
See the CHRN income statement, the CHRN chart for price history, or the CHRN stock overview for the latest quote and news.
CHRN key metrics FAQ
What is ChronoScale's EV/EBITDA?
ChronoScale's enterprise value was 128.8 times EBITDA at the end of fiscal 2026 (enterprise value $2.7 billion, EBITDA $20.6 million); the current EV/EBITDA is 151.1.
What is ChronoScale's return on equity?
ChronoScale's return on equity (ROE) was −39.3% in fiscal 2026: net income of -$50.3 million on average shareholders' equity of $128.1 million.
What is ChronoScale's ROIC?
ChronoScale's return on invested capital was −22.7% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does ChronoScale have?
ChronoScale had total debt of $0.5 million at the end of fiscal 2026, a debt-to-equity ratio of 0.00 and more cash than debt.
Does ChronoScale buy back its shares?
Yes. ChronoScale spent $0.8 million on net share repurchases in fiscal 2026 Shares outstanding changed +1.5% over the year, to 145.2M..
What is ChronoScale's free cash flow yield?
ChronoScale generated $12.2 million of free cash flow in fiscal 2026, a free cash flow yield of 0.5% on its market value at year-end ($2.7 billion).
What is ChronoScale's current ratio?
ChronoScale's current ratio was 0.51 at the end of fiscal 2026: current assets were 0.51 times current liabilities.